- Home
- NURO vs ONVO Comparison
NURO vs ONVO Comparison
Compare NURO & ONVO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NURO
- ONVO
- Stock Information
- Founded
- NURO 1996
- ONVO 2007
- Country
- NURO United States
- ONVO United States
- Employees
- NURO N/A
- ONVO N/A
- Industry
- NURO Medical/Dental Instruments
- ONVO Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- NURO Health Care
- ONVO Health Care
- Exchange
- NURO Nasdaq
- ONVO Nasdaq
- Market Cap
- NURO 7.6M
- ONVO 6.5M
- IPO Year
- NURO N/A
- ONVO N/A
- Fundamental
- Price
- NURO $4.05
- ONVO $0.39
- Analyst Decision
- NURO
- ONVO
- Analyst Count
- NURO 0
- ONVO 0
- Target Price
- NURO N/A
- ONVO N/A
- AVG Volume (30 Days)
- NURO 28.9K
- ONVO 243.5K
- Earning Date
- NURO 02-20-2025
- ONVO 02-06-2025
- Dividend Yield
- NURO N/A
- ONVO N/A
- EPS Growth
- NURO N/A
- ONVO N/A
- EPS
- NURO N/A
- ONVO N/A
- Revenue
- NURO $3,767,764.00
- ONVO $103,000.00
- Revenue This Year
- NURO N/A
- ONVO $59.08
- Revenue Next Year
- NURO N/A
- ONVO $18.24
- P/E Ratio
- NURO N/A
- ONVO N/A
- Revenue Growth
- NURO N/A
- ONVO N/A
- 52 Week Low
- NURO $2.66
- ONVO $0.32
- 52 Week High
- NURO $4.73
- ONVO $1.74
- Technical
- Relative Strength Index (RSI)
- NURO 54.09
- ONVO 47.81
- Support Level
- NURO $3.93
- ONVO $0.34
- Resistance Level
- NURO $4.13
- ONVO $0.51
- Average True Range (ATR)
- NURO 0.11
- ONVO 0.06
- MACD
- NURO 0.01
- ONVO -0.00
- Stochastic Oscillator
- NURO 70.37
- ONVO 30.00
About NURO NeuroMetrix Inc.
NeuroMetrix Inc is a commercial-stage healthcare company. Its core business activities are integrated with in-house capabilities spanning product development, manufacturing, regulatory affairs and compliance, sales and marketing, and customer support. The company produces bioelectrical and digital medicine to address chronic health conditions including chronic pain, sleep disorders, and diabetes. The product line of the company includes Wearable neuro-stimulation therapeutic devices and Point-of-care neuropathy diagnostic tests. The company operates in a single segment being Medical equipment and consumables.
About ONVO Organovo Holdings Inc.
Organovo Holdings Inc is a biotechnology company focused on developing FXR314 in inflammatory bowel disease (IBD), including ulcerative colitis (UC), based on demonstration of clinical promise in three-dimensional (3D) human tissues as well as preclinical data. FXR is a mediator of gastrointestinal and liver diseases.